Kanagawa O, Nagasawa R
Lilly Research Laboratories, a Division of Eli Lilly and Company, La Jolla, CA 92037.
J Immunol. 1987 Dec 15;139(12):3991-5.
Two monoclonal antibodies (mAb) directed to the dual reactive cytolytic T lymphocyte clone OH8 (Db + H-Y and H-2d) were established. Analysis by cell surface staining and immunoprecipitation of radiolabeled surface molecules of OH8 followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that both mAb recognized an identical heterodimeric, clonotypic structure on OH8 cells, i.e., T cell receptor. However, although the MR3-2 mAb inhibited the lysis of either Db + H-Y or H-2d targets by OH8, the MR3-6 mAb inhibited the lysis of H-2d target cells, but not that of Db + H-Y target cells. Modulation of T cell receptor by either MR3-2 or MR3-6 mAb rendered the OH8 cytolytic T lymphocyte incapable of killing both Db + H-Y and H-2d target cells. These findings suggest that different epitopes of OH8 T cell receptor were involved for the recognition of self + antigen and alloantigen.
建立了两种针对双反应性细胞溶解性T淋巴细胞克隆OH8(Db + H-Y和H-2d)的单克隆抗体(mAb)。通过细胞表面染色以及对OH8放射性标记表面分子进行免疫沉淀,随后进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析,结果显示两种单克隆抗体在OH8细胞上识别出相同的异二聚体克隆型结构,即T细胞受体。然而,尽管MR3-2单克隆抗体抑制了OH8对Db + H-Y或H-2d靶细胞的杀伤作用,但MR3-6单克隆抗体仅抑制了OH8对H-2d靶细胞的杀伤作用,而不影响其对Db + H-Y靶细胞的杀伤。MR3-2或MR3-6单克隆抗体对T细胞受体的调节使得OH8细胞溶解性T淋巴细胞无法杀伤Db + H-Y和H-2d靶细胞。这些发现表明,OH8 T细胞受体的不同表位参与了自身+抗原和同种抗原的识别。